当前位置：
X-MOL 学术
›
N. Engl. J. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Oral Relugolix for Androgen-Deprivation Therapy in Advanced Prostate Cancer
The New England Journal of Medicine ( IF 96.2 ) Pub Date : , DOI: 10.1056/nejmoa2004325 Neal D Shore 1 , Fred Saad 1 , Michael S Cookson 1 , Daniel J George 1 , Daniel R Saltzstein 1 , Ronald Tutrone 1 , Hideyuki Akaza 1 , Alberto Bossi 1 , David F van Veenhuyzen 1 , Bryan Selby 1 , Xiaolin Fan 1 , Vicky Kang 1 , Jackie Walling 1 , Bertrand Tombal 1 ,
The New England Journal of Medicine ( IF 96.2 ) Pub Date : , DOI: 10.1056/nejmoa2004325 Neal D Shore 1 , Fred Saad 1 , Michael S Cookson 1 , Daniel J George 1 , Daniel R Saltzstein 1 , Ronald Tutrone 1 , Hideyuki Akaza 1 , Alberto Bossi 1 , David F van Veenhuyzen 1 , Bryan Selby 1 , Xiaolin Fan 1 , Vicky Kang 1 , Jackie Walling 1 , Bertrand Tombal 1 ,
Affiliation
New England Journal of Medicine, Ahead of Print.
中文翻译：
用于晚期前列腺癌雄激素剥夺治疗的口服 Relugolix
新英格兰医学杂志，提前印刷。
更新日期：2020-05-30
中文翻译：
用于晚期前列腺癌雄激素剥夺治疗的口服 Relugolix
新英格兰医学杂志，提前印刷。
京公网安备 11010802027423号